Dr. Tager received his M.D. from Harvard Medical School and completed both his internal medicine residency and his pulmonary and critical care medicine fellowship at the MGH. Dr. Tager began his own laboratory after his post-doctoral research training in the laboratory of Dr. Andrew Luster, also at the MGH. Dr. Tager’s laboratory focuses on two separate areas of investigation, (1) the pathogenesis of idiopathic pulmonary fibrosis, scleroderma and other fibrotic diseases, focusing on bioactive lipid mediators, (2) and anti-HIV immunity, using an improved humanized mouse model of HIV infection.